Basilea Pharmaceutica
BSLN.SW
#6588
Rank
C$0.80 B
Marketcap
$66.70
Share price
0.12%
Change (1 day)
24.00%
Change (1 year)

EPS for Basilea Pharmaceutica (BSLN.SW)

EPS in 2023: $1.48

According to Basilea Pharmaceutica's latest financial reports the company's current EPS (TTM) is $1.48. In 2023 the company made an earnings per share (EPS) of $1.48 a decrease over its 2022 EPS that were of $1.58.

EPS history for Basilea Pharmaceutica from 2002 to 2023

Annual EPS

Year EPS Change
2023$1.48-6.28%
2022$1.58-273.94%
2021-$0.91-60.87%
2020-$2.32-24.46%
2019-$3.07-26.92%
2018-$4.2059.83%
2017-$2.63-63.06%
2016-$7.12-19.26%
2015-$8.8246.12%
2014-$6.0410.07%
2013-$5.48-36.76%
2012-$8.67-5.42%
2011-$9.17-153.36%
2010$17.18-198.47%
2009-$17.45-15.34%
2008-$20.6116.7%
2007-$17.6636.07%
2006-$12.9879.07%
2005-$7.25-46.79%
2004-$13.629.83%
2003-$12.40-34.23%
2002-$18.85